Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China
· Delayed Price · Currency is CNY 5.10
+0.05 (0.99%)
Apr 30, 2025, 3:04 PM CST
SHE:300639 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -950.35 | 140.47 | 1,726 | 852.16 | 362.66 | Upgrade
|
| Depreciation & Amortization | 169.77 | 174.77 | 178.89 | 87.3 | 50.04 | Upgrade
|
| Other Amortization | 28.63 | 17.56 | 14.2 | 16.68 | 13.85 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.25 | -7.06 | -4.34 | -2.34 | -5.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | 34.36 | -1.56 | 291.75 | 6.34 | 0.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.15 | -13.94 | -21.35 | -20.6 | -5.33 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -10.76 | 250.48 | - | - | Upgrade
|
| Other Operating Activities | 609.26 | -54.85 | 176.49 | 40.18 | 32.8 | Upgrade
|
| Change in Accounts Receivable | 161.22 | 873.52 | -1,920 | -648.08 | -275.72 | Upgrade
|
| Change in Inventory | 18.16 | 52.38 | -63.36 | -51.15 | -53.21 | Upgrade
|
| Change in Accounts Payable | -113.45 | -802.73 | 698.97 | 289.93 | 156.22 | Upgrade
|
| Change in Other Net Operating Assets | 11.59 | 11.44 | 61.48 | -17.77 | 4.88 | Upgrade
|
| Operating Cash Flow | 78.78 | 319.6 | 1,309 | 631.34 | 311.3 | Upgrade
|
| Operating Cash Flow Growth | -75.35% | -75.59% | 107.37% | 102.81% | 175.90% | Upgrade
|
| Capital Expenditures | -148.33 | -385.32 | -734.37 | -641.07 | -287.12 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.4 | 17.74 | 13.72 | 6.34 | 6.92 | Upgrade
|
| Investment in Securities | 37.58 | 74.73 | 115.89 | 131.39 | -909.67 | Upgrade
|
| Other Investing Activities | - | 7.64 | - | - | - | Upgrade
|
| Investing Cash Flow | -110.35 | -285.21 | -604.75 | -503.35 | -1,190 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 248.33 | 81.27 | Upgrade
|
| Long-Term Debt Issued | 55.32 | 79.86 | 200.79 | - | - | Upgrade
|
| Total Debt Issued | 55.32 | 79.86 | 200.79 | 248.33 | 81.27 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -172.27 | -6 | Upgrade
|
| Long-Term Debt Repaid | -11.62 | -163.82 | -265.91 | -8.25 | -0.08 | Upgrade
|
| Total Debt Repaid | -11.62 | -163.82 | -265.91 | -180.52 | -6.08 | Upgrade
|
| Net Debt Issued (Repaid) | 43.7 | -83.97 | -65.12 | 67.81 | 75.19 | Upgrade
|
| Issuance of Common Stock | - | - | 10 | 70.25 | 1,037 | Upgrade
|
| Repurchase of Common Stock | - | -50 | -50 | -49.97 | -50.18 | Upgrade
|
| Common Dividends Paid | -44.46 | -160.46 | -114.29 | -76.09 | -43.76 | Upgrade
|
| Other Financing Activities | -74.51 | 0.02 | -0 | -3.5 | -2.05 | Upgrade
|
| Financing Cash Flow | -75.27 | -294.4 | -219.41 | 8.5 | 1,017 | Upgrade
|
| Foreign Exchange Rate Adjustments | 7.59 | 0.95 | 13.4 | -5.48 | -4.37 | Upgrade
|
| Net Cash Flow | -99.25 | -259.07 | 498.46 | 131.01 | 133.63 | Upgrade
|
| Free Cash Flow | -69.55 | -65.72 | 574.85 | -9.73 | 24.18 | Upgrade
|
| Free Cash Flow Margin | -8.53% | -5.95% | 10.27% | -0.36% | 1.79% | Upgrade
|
| Free Cash Flow Per Share | -0.11 | -0.12 | 0.87 | -0.01 | 0.04 | Upgrade
|
| Cash Income Tax Paid | 117.22 | 364.68 | 311.22 | 171.2 | 94.69 | Upgrade
|
| Levered Free Cash Flow | 442.46 | -76.67 | 74.02 | -231.66 | -129.29 | Upgrade
|
| Unlevered Free Cash Flow | 442.46 | -73.58 | 79.14 | -227.03 | -128.79 | Upgrade
|
| Change in Net Working Capital | -507.36 | -126.57 | 900.52 | 350.64 | 187.34 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.